Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 BiogenSeattle GeneticsNOVOZYMES A/S/SNeurocrine BiosciencesQiagen
SymbolNASDAQ:BIIBNASDAQ:SGENOTCMKTS:NVZMYNASDAQ:NBIXNYSE:QGEN
Price Information
Current Price$238.79$74.01$42.77$100.83$33.67
52 Week RangeHoldBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$270.00$85.2727N/A$106.5556$42.40
% Upside from Price Target13.07% upside15.22% upsideN/A5.68% upside25.93% upside
Trade Information
Market Cap$43.46 billion$11.77 billion$12.84 billion$9.30 billion$7.63 billion
Beta1.011.970.761.260.88
Average Volume1,369,262559,04620,150635,910823,443
Sales & Book Value
Annual Revenue$13.45 billion$654.70 million$2.28 billion$451.24 million$1.50 billion
Price / Sales3.2718.285.5720.465.06
Cashflow$32.1819 per shareN/A$1.7033 per share$0.4980 per share$2.4452 per share
Price / Cash7.42N/A25.11202.4613.77
Book Value$64.68 per share$7.95 per share$6.10 per share$5.30 per share$11.69 per share
Price / Book3.699.317.0119.022.88
Profitability
Net Income$4.43 billion$-222,690,000.00$511 million$21.11 million$190.38 million
EPS$26.20($1.65)$1.75$0.22$1.34
Trailing P/E Ratio9.11N/A24.44458.3225.13
Forward P/E Ratio7.42N/A25.1630.0121.45
P/E Growth$1.19N/A$2.05$6.25$2.07
Net Margins37.62%-36.94%22.31%2.98%12.94%
Return on Equity (ROE)44.89%-17.16%28.54%0.46%12.10%
Return on Assets (ROA)23.23%-14.39%16.00%0.21%5.76%
Dividend
Annual PayoutN/AN/A$0.50N/AN/A
Dividend YieldN/AN/A1.17%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A28.57%N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.49%N/A0.05%0.96%0.54%
Current Ratio2.46%3.03%1.27%7.44%1.77%
Quick Ratio2.22%2.70%0.71%7.32%1.59%
Ownership Information
Institutional Ownership Percentage86.17%98.86%0.18%96.10%62.10%
Insider Ownership Percentage0.39%33.80%N/A4.30%9.00%
Miscellaneous
Employees7,8001,3026,4275854,952
Shares Outstanding184.45 million161.72 million297.00 million91.58 million225.51 million
Next Earnings Date10/22/2019 (Estimated)10/24/2019 (Estimated)10/23/2019 (Estimated)11/4/2019 (Estimated)11/4/2019 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
 BiogenSeattle GeneticsNOVOZYMES A/S/SNeurocrine BiosciencesQiagen

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel